", "sentences": [], "annotations": [], "relations": []}, {"offset": 36190, "infons": {"section_type": "REF", "type": "title"}, "text": "References", "sentences": [], "annotations": [], "relations": []}, {"offset": 36201, "infons": {"fpage": "11472", "lpage": "7", "name_0": "surname:Aharoni;given-names:R", "name_1": "surname:Teitelbaum;given-names:D", "name_2": "surname:Leitner;given-names:O", "pub-id_pmid": "11027347", "section_type": "REF", "source": "Proc Natl Acad Sci U S A", "type": "ref", "volume": "97", "year": "2000"}, "text": "Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1", "sentences": [], "annotations": [], "relations": []}, {"offset": 36344, "infons": {"fpage": "59", "lpage": "62", "name_0": "surname:Avasarala;given-names:JR", "name_1": "surname:Cross;given-names:AH", "name_2": "surname:Clifford;given-names:DB", "pub-id_pmid": "12617270", "section_type": "REF", "source": "Mult Scler", "type": "ref", "volume": "9", "year": "2003"}, "text": "Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 36436, "infons": {"fpage": "1165", "lpage": "74", "name_0": "surname:Bayless;given-names:KJ", "name_1": "surname:Meininger;given-names:GA", "name_2": "surname:Scholtz;given-names:JM", "pub-id_pmid": "9547293", "section_type": "REF", "source": "J Cell Sci", "type": "ref", "volume": "111", "year": "1998"}, "text": "Osteopontin is a ligand for the alphabeta1 integrin", "sentences": [], "annotations": [], "relations": []}, {"offset": 36488, "infons": {"fpage": "s61 P130", "issue": "suppl 1", "name_0": "surname:Bennett;given-names:D", "name_1": "surname:Ludden;given-names:T", "name_2": "surname:Shah;given-names:J", "section_type": "REF", "source": "Mult Scler", "type": "ref", "volume": "8", "year": "2002"}, "text": "The use of pharmacokinetic (PK) modeling and efficacy data to establish optimal dosing of natalizumab (Antegren ) [abstract]", "sentences": [], "annotations": [], "relations": []}, {"offset": 36615, "infons": {"fpage": "2871", "lpage": "5", "name_0": "surname:Burkly;given-names:LC", "name_1": "surname:Jakubowski;given-names:A", "name_2": "surname:Newman;given-names:BM", "pub-id_pmid": "1718763", "section_type": "REF", "source": "Eur J Immunol", "type": "ref", "volume": "21", "year": "1991"}, "text": "Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T-cell proliferation", "sentences": [], "annotations": [], "relations": []}, {"offset": 36729, "infons": {"comment": "in press", "name_0": "surname:Calabresi;given-names:P", "name_1": "surname:Giovannoni;given-names:G", "name_2": "surname:Confavreux;given-names:C", "section_type": "REF", "source": "Neurology", "type": "ref", "year": "2007"}, "text": "Incidence and clinical significance of antibodies during treatment with natalizumab: 2 year results from AFFIRM and SENTINEL", "sentences": [], "annotations": [], "relations": []}, {"offset": 36854, "infons": {"fpage": "965", "lpage": "70", "name_0": "surname:Carlos;given-names:TM", "name_1": "surname:Schwartz;given-names:BR", "name_2": "surname:Kovach;given-names:NL", "pub-id_pmid": "1697486", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "76", "year": "1990"}, "text": "Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells", "sentences": [], "annotations": [], "relations": []}, {"offset": 36973, "infons": {"fpage": "59", "lpage": "74", "name_0": "surname:Clark;given-names:W", "name_1": "surname:Mucklow;given-names:J", "name_2": "surname:In Panton;given-names:R", "name_3": "surname:Chapman;given-names:S", "section_type": "REF", "source": "Medicines management", "type": "ref", "year": "1998"}, "text": "Gathering and weighing the evidence", "sentences": [], "annotations": [], "relations": []}, {"offset": 37009, "infons": {"fpage": "S28", "issue": "12 suppl 6", "lpage": "32", "name_0": "surname:Cohen;given-names:BA", "name_1": "surname:Mikol;given-names:DD", "pub-id_pmid": "15623667", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "63", "year": "2004"}, "text": "Mitoxantrone treatment of multiple sclerosis: safety considerations", "sentences": [], "annotations": [], "relations": []}, {"offset": 37077, "infons": {"fpage": "407", "lpage": "13", "name_0": "surname:Dalton;given-names:CM", "name_1": "surname:Miszkiel;given-names:KA", "name_2": "surname:Barker;given-names:GJ", "pub-id_pmid": "15083284", "section_type": "REF", "source": "J Neurol", "type": "ref", "volume": "251", "year": "2004"}, "text": "Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis", "sentences": [], "annotations": [], "relatio